This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Absolute Antibody
product type :
antibody
product name :
Anti-CD200R [OX108]
catalog :
Ab00118-1.4
quantity :
200 μg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
OX108
The same clone is also sold as:
The same clone is also sold as:
- BioLegend: 329315, 329307, 329316, 329317, 329312, 329302, 329308, 329306, 329310, 329319, 329305, 329311, 329313, 329309, 329314
- Abnova: RAB03191, MAB5234, RAB03190
- Abcam: ab33366
- OriGene: AM01069RP-T, AM01069RP-N, AM01069PU-N
- Santa Cruz Biotechnology: sc-53102 L, sc-53102
- Bio-Rad: MCA2282T, MCA2282A647T, MCA2282A488, MCA2282A647, MCA2282PET, MCA2282A488T, MCA2282PE, MCA2282
- Invitrogen: 46-9201-42, 16-9201-85, 16-9201-82, MA1-82694, 12-9201-42, MA5-47765, 14-9201-82, MA5-47764
reactivity :
human
application :
flow cytometry
product information
Product Name :
Anti-CD200R [OX108]
Catalog Number :
Ab00118-1.4
Target :
CD200R
Antibody Species :
Mouse
Isotype :
IgG1
LCFormat :
kappa
Heavy Chain modification :
Fc Silent™
Target Synonyms :
CD200 Receptor; CD200 Cell surface glycoprotein receptor; Cell surface glycoprotein OX2 receptor 1; CD200R1; CD200R; OX2R; CD200 receptor-like 2; HuCD200R2; CD200RLa
Display Amount :
200 μg
PriceGBP :
285
PriceEUR :
315
Product Type :
Primary Antibody
Clonality :
Monoclonal
ApplicationCodesClone :
FC
Immunogen :
Recombinant protein - hCD200RCD4d3+4.
MarketingCategories :
immunology; biotherapeuticresearch; inflammation
Available Custom Conjugation Options :
AP, HRP, Fluorescein, APC, PE, Biotin Type A, Biotin Type B, Streptavidin, FluoroProbes 647H, Atto488, APC/Cy7, PE/Cy7
UniprotAccessionNo :
Q8TD46
Product Description :
This is a recombinant monoclonal antibody.
company information
Absolute Antibody
Wilton Centre
Redcar
Cleveland
TS10 4RF
Redcar
Cleveland
TS10 4RF
info@absoluteantibody.com
https://absoluteantibody.com/1-617-377-4057
headquarters: United Kingdom
questions and comments